Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pharmacy services review could address wrong AF treatments

RPS supports the use of pharmacists' clinical skills to assist the quarter of a million atrial fibrillation patients on the wrong treatment


A government-commissioned review of pharmacy services could address the quarter of a million atrial fibrillation (AF) patients currently on the wrong treatment, the Royal Pharmaceutical Society (RPS) has said.

Campaign group AF 180 Degrees highlighted last week that more than 260,000 AF patients are either not receiving preventative treatment or are only taking aspirin, despite the National Institute of Clinical Excellence (Nice) no longer recommending this as treatment.

These patients could be at greater risk of stroke, the campaign group stressed. 

Pharmacy services review

In response to the findings, RPS English pharmacy board chair Sandra Gidley highligted that the forthcoming Murray Review – led by the King's Fund-led and due to be completed by October – will be looking at the clinical services provided by community pharmacy.

"Using pharmacists’ clinical and prescribing skills, combined with a greater role in supporting people with long-term conditions, is the way forward to making sure AF patients are on the right treatment," Ms Gidley told C+D today (June 20).

“One of the biggest problem with [AF patients] is under-diagnosis,” Ms Gidley added.

AF 180 Degrees took its figures from anonymised GP practice data, which revealed that 13.5% of the 895,000 patients reviewed were only receiving aspirin for stroke prevention in 2016, while 15.7% were receiving no treatment at all. 

Read more about the study, as well as current Nice guidelines for AF patients, here



How do you support your AF patients?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content


Pharmacy Manager
Newquay, Cornwall
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts